Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Barriers to ART initiation in HIV infected subjects and with treatment indication in Spain. Why don't they start their treatment? Bridgap Study].
Viciana-Fernández P, Falcó V, Castaño M, de los Santos-Gil I, Olalla-Sierra J, Hernando A, Deig E, Clotet B, Knobel H, Podzamczer D, Pedrol PD; Grupo de trabajo Bridgap. Viciana-Fernández P, et al. Among authors: falco v. Enferm Infecc Microbiol Clin. 2015 Jun-Jul;33(6):397-403. doi: 10.1016/j.eimc.2014.06.012. Epub 2015 Jan 7. Enferm Infecc Microbiol Clin. 2015. PMID: 25577557 Spanish.
Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults.
Ribera E, Lopez RM, Diaz M, Pou L, Ruiz L, Falcó V, Crespo M, Azuaje C, Ruiz I, Ocaña I, Clotet B, Pahissa A. Ribera E, et al. Among authors: falco v. Antimicrob Agents Chemother. 2004 Nov;48(11):4256-62. doi: 10.1128/AAC.48.11.4256-4262.2004. Antimicrob Agents Chemother. 2004. PMID: 15504850 Free PMC article. Clinical Trial.
[Treatment for Legionnaires' disease. Macrolides or quinolones?].
Falcó V, Molina I, Juste C, Crespo M, Almirante B, Pigrau C, Ferrer A, Bravo C, Palomar M, Pahissa A. Falcó V, et al. Enferm Infecc Microbiol Clin. 2006 Jun-Jul;24(6):360-4. doi: 10.1157/13089688. Enferm Infecc Microbiol Clin. 2006. PMID: 16792936 Spanish.
Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality.
Alvarez-Martínez MJ, Moreno A, Miró JM, Valls ME, Rivas PV, de Lazzari E, Sued O, Benito N, Domingo P, Ribera E, Santín M, Sirera G, Segura F, Vidal F, Rodríguez F, Riera M, Cordero ME, Arribas JR, Jiménez de Anta MT, Gatell JM, Wilson PE, Meshnick SR; Spanish PCP Working Group. Alvarez-Martínez MJ, et al. Diagn Microbiol Infect Dis. 2008 Sep;62(1):34-43. doi: 10.1016/j.diagmicrobio.2008.04.016. Epub 2008 Jun 12. Diagn Microbiol Infect Dis. 2008. PMID: 18554841
Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study.
Falcó V, Olmo M, del Saz SV, Guelar A, Santos JR, Gutiérrez M, Colomer D, Deig E, Mateo G, Montero M, Pedrol E, Podzamczer D, Domingo P, Llibre JM. Falcó V, et al. J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):26-31. doi: 10.1097/QAI.0b013e31817bec64. J Acquir Immune Defic Syndr. 2008. PMID: 18667930
The changing face of HIV/AIDS in treated patients.
Llibre JM, Falco V, Tural C, Negredo E, Pineda JA, Muñoz J, Ortega E, Videla S, Sirera G, Martinez E, Miralles C, Iribarren J, Galindo MJ, Domingo P, d'Arminio-Monforte A, Miro JM, Clotet B. Llibre JM, et al. Among authors: falco v. Curr HIV Res. 2009 Jul;7(4):365-77. doi: 10.2174/157016209788680633. Curr HIV Res. 2009. PMID: 19601771 Review.
Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals.
Imaz A, Llibre JM, Mora M, Mateo G, Camacho A, Blanco JR, Curran A, Santos JR, Caballero E, Bravo I, Gayá F, Domingo P, Rivero A, Falcó V, Clotet B, Ribera E. Imaz A, et al. Among authors: falco v. J Antimicrob Chemother. 2011 Feb;66(2):358-62. doi: 10.1093/jac/dkq432. Epub 2010 Dec 14. J Antimicrob Chemother. 2011. PMID: 21172789
Q fever endocarditis in Spain. Clinical characteristics and outcome.
Mogollón MV, Anguita MP, Aguado JM, Tornos P, Miró JM, Gálvez-Acebal J, Muñoz-Sanz A, Fariñas MC, Fernández-Guerrero M, Vilacosta I, Muñoz P, Montejo-Baranda JM, Hidalgo-Tenorio C, Falcó V, del Río A, Arnaíz AM, San-Feliú I, de Alarcón A; Spanish Q Fever Endocarditis Group. Mogollón MV, et al. Among authors: falco v. Enferm Infecc Microbiol Clin. 2011 Feb;29(2):109-16. doi: 10.1016/j.eimc.2010.07.015. Epub 2011 Feb 17. Enferm Infecc Microbiol Clin. 2011. PMID: 21333397
Changes in body composition and mitochondrial DNA in HIV-1-infected patients switching to fixed-dose abacavir/lamivudine or tenofovir/emtricitabine: a substudy of the BICOMBO trial.
Curran A, Martinez E, Podzamczer D, Lonca M, Barragan P, Crespo M, Falco V, Vidal-Sicart S, Imaz A, Martinez M, Gatell JM, Ribera E. Curran A, et al. Among authors: falco v. Antivir Ther. 2012;17(4):711-8. doi: 10.3851/IMP2081. Epub 2012 Feb 28. Antivir Ther. 2012. PMID: 22374987 Clinical Trial.
341 results